PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
14-Aug-2024 Cellomatics underpins continued US and European expansion with two business development hires Cellomatics Biosciences
14-Aug-2024 New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease
14-Aug-2024 NEJM publishes positive results for nipocalimab Phase 2 UNITY clinical study for early onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). Johnson & Johnson
12-Aug-2024 LAC Spotlights Brain Health Amid Growing Stress Concerns in Singapore, Features Brain-Boosting Supplements to Combat Damage From Stressors LAC Global
12-Aug-2024 Q&M Dental Group's profit after tax grew 84%, Board declared 0.40 cent interim dividend, a 150% increase over the same period last year Q&M Dental Group Ltd
12-Aug-2024 Biopharmaceuticals Market is Predicted to Reach $974 Billion with a CAGR of 12% by 2030 Next Move Strategy Consulting
09-Aug-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024 Nxera Pharma
09-Aug-2024 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, for the Treatment of Patients with Moderate to Severe Osteoarthritis Levicept
09-Aug-2024 Valneva Scotland Receives Prestigious Award for Health and Safety Excellence Valneva
07-Aug-2024 CLINIGEN ACQUIRES KINESYS CONSULTING TO BOLSTER REGULATORY AFFAIRS EXPERTISE Clinigen
07-Aug-2024 XF-73 treatment of MRSA burn wound infection prevents bacterial invasion of the bloodstream Destiny Pharma plc
07-Aug-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
07-Aug-2024 New results from AlzeCure's pain project TrkA-NAM presented at the pain conference IASP 2024 AlzeCure Pharma AB
07-Aug-2024 Release Therapeutics Secures CHF 3.3 Million in Seed Funding Release Therapeutics
07-Aug-2024 Velocity appoints ICON exec Rachael Buck Ph.D. as Head of U.K. Velocity Clinical Research
07-Aug-2024 Kyowa Kirin International and NewBridge Pharmaceuticals enter into agreement to improve access to medicines for rare disease patients across Middle East and North Africa Kyowa Kirin International
07-Aug-2024 Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials Lindus Health
07-Aug-2024 Pharmanovia appoints new General Manager for the DACH region Pharmanovia
06-Aug-2024 Integrated DNA Technologies Bolsters Synthetic Biology Portfolio with Launch of Rapid Genes and Significant Upgrades to Gene Synthesis Offerings Integrated DNA Technologies
06-Aug-2024 Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation Clinion Inc